{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-013436","form_type":"8-K","ticker":"ATXI","cik":"0001644963","company_name":"AVENUE THERAPEUTICS, INC.","filed_at":"2024-04-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.401190+00:00","generated_at":"2026-06-03T06:30:59.227561+00:00","sec_items":["3.03","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Avenue Therapeutics effects 1-for-75 reverse stock split to meet Nasdaq bid price rule","bullets":["Reverse split effective April 26, 2024; shares reduced from ~44.7M to ~0.6M.","Split is to bring Company into compliance with Nasdaq $1.00 minimum bid price.","No fractional shares; fraction holders get rounded up to next whole share.","Ticker remains ATXI; new CUSIP 05360L403. VStock Transfer is exchange agent.","Holders via brokers need no action; physical certificate holders will receive instructions."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-013436","json":"https://secwatch.observer/filing/0001437749-24-013436.json","markdown":"https://secwatch.observer/filing/0001437749-24-013436.md","text":"https://secwatch.observer/filing/0001437749-24-013436.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1644963/000143774924013436/0001437749-24-013436-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1644963/000143774924013436/atxi20240423_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T06:30:59.227561+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c397a18f53d78f1f440e5f59c2ade38d759eae91","claim":"AVENUE THERAPEUTICS, INC.: Filed Certificate of Amendment to effect a 1-for-75 reverse stock split of common stock (effective 2024-04-26).","evidence_excerpt":"On April 25, 2024, Avenue Therapeutics, Inc. (the “ Company ”) filed a Certificate of Amendment to its Third Amended and Restated Certificate of Incorporation (the “ Amendment ”) with the Secretary of State of the State of Delaware to effect a 1-for-75 reverse stock split","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1644963/000143774924013436/0001437749-24-013436-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2024-04-26"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}